Form 4: Vital Farms Executive Kathryn McKeon Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Kathryn McKeon, Chief Marketing Officer of Vital Farms, exercised stock options and sold 12,300 shares of common stock at an average price of $42.08, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Summary
- On January 13, 2025, Kathryn McKeon, the Chief Marketing Officer of Vital Farms, Inc., executed a stock option to acquire 12,300 shares of common stock at a price of $3.2461 per share.
- Simultaneously, McKeon sold 12,300 shares of Vital Farms common stock at a weighted average price of $42.08 per share, with prices ranging from $42.00 to $42.28.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 28, 2024.
- Following these transactions, McKeon directly owns 46,203 shares of Vital Farms common stock.
- McKeon also granted a Power of Attorney to Joanne Bal, Kevin Trempe, Francis Cullo, Jaime Chase, and Jason Minio to handle SEC filings on her behalf.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive under a pre-arranged plan. There's no indication of positive or negative implications for the company.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, suggesting they were planned well in advance and not based on immediate market sentiment.
Future Outlook
There is no future outlook provided in this document.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Executives often have stock options as part of their compensation, and their exercise and sale are subject to regulatory reporting requirements.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly listed companies like Vital Farms.
- Comparable companies such as Cal-Maine Foods and Post Holdings also experience similar filings related to stock options and share sales by their executives.
- The reporting requirements and regulations surrounding these transactions are standardized across the industry to ensure transparency and prevent illegal insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sale mitigates concerns about insider information being used for personal gain.
Key Dates
| Date | Description |
|---|---|
| 2024-05-28 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 2024-12-10 | Date of Power of Attorney execution |
| 2025-01-13 | Date of stock option exercise and share sale |
| 2025-01-15 | Date of signature for the Form 4 filing |
| 2026-09-12 | Expiration date of Employee Stock Option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.